These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3119546)

  • 41. The search for new hypoxic cell radiosensitizers.
    Mansfield CM; Kimler BF; Cheng CC; Abrahams IL; Podrebarac EG; Wittek PJ; Reddy EK
    J Natl Med Assoc; 1980 Aug; 72(8):765-9. PubMed ID: 7401185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiosensitizing and cytotoxic properties of DNA targeted phenanthridine-linked nitroheterocycles of varying electron affinities.
    Cowan DS; Matejovic JF; Wardman P; McClelland RA; Rauth AM
    Int J Radiat Biol; 1994 Dec; 66(6):729-38. PubMed ID: 7814971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 2-Alkylsulfonyloxy-3-hydroxy-1,4-naphthoquinones: a novel class of radio- and chemosensitizers of V79 cells.
    Hatzigrigoriou E; Papadopoulou MV; Shields D; Bloomer WD
    Oncol Res; 1993; 5(1):29-36. PubMed ID: 8369573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo testing of hypoxic radiosensitizers using the KHT murine tumour assayed by the lung-colony technique.
    Rauth AM; Kaufman K
    Br J Radiol; 1975 Mar; 48(567):209-20. PubMed ID: 1125550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytotoxicity, radiosensitization, and DNA interaction of platinum complexes of thiazin and xanthene dyes.
    Teicher BA; Herman TS; Kaufmann ME
    Radiat Res; 1990 Feb; 121(2):187-95. PubMed ID: 2305037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of radiosensitizers on the survival response of hypoxic mammalian cells: the low X-ray dose region, hypersensitivity and induced radioresistance.
    Skov KA; MacPhail HS; Marples B
    Radiat Res; 1994 Apr; 138(1 Suppl):S113-6. PubMed ID: 8146312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Synthesis and radiosensitizing activity of nitro-arylimino-diethyl-sodium thiosulfate and nitro phenylalanine derivatives].
    Liu HX; Hu B; Li Z; Mi FS; Shen Y
    Yao Xue Xue Bao; 1992; 27(8):632-7. PubMed ID: 1481683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology.
    Weinmann M; Welz S; Bamberg M
    Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):364-74. PubMed ID: 12871083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glyoxylic compounds as radiosensitizers of hypoxic cells.
    Cornago MP; Lopez Zumel MC; Alvarez MV; Izquierdo MC
    Biochem Med Metab Biol; 1990 Jun; 43(3):253-62. PubMed ID: 2383429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of a series of nitrothiophenes with basic or electrophilic substituents and evaluation as radiosensitizers and as bioreductively activated cytotoxins.
    Threadgill MD; Webb P; O'Neill P; Naylor MA; Stephens MA; Stratford IJ; Cole S; Adams GE; Fielden EM
    J Med Chem; 1991 Jul; 34(7):2112-20. PubMed ID: 2066984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting tumors with hypoxia-activated cytotoxins.
    Ahn GO; Brown M
    Front Biosci; 2007 May; 12():3483-501. PubMed ID: 17485316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nitropyrrole radiosensitizers: structure function relationships.
    Raleigh JA; Chapman JD; Reuvers AP; Biaglow JE; Durand RE; Rauth AM
    Br J Cancer Suppl; 1978 Jun; 3():6-10. PubMed ID: 277259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro studies on the radioresistance of oxic and hypoxic cells in the presence of both radioprotective and radiosensitizing drugs.
    Yuhas JM; Li AP
    Radiat Res; 1978 Sep; 75(3):563-72. PubMed ID: 724986
    [No Abstract]   [Full Text] [Related]  

  • 55. The use of hypoxic cell radiosensitizers with mixed X and alpha radiations.
    Raju MR; Frank JP; Bain E; Trujillo TT
    Radiat Res; 1977 Jul; 71(1):233-9. PubMed ID: 560028
    [No Abstract]   [Full Text] [Related]  

  • 56. Failla Memorial Lecture. Redox, radiation, and reductive bioactivation.
    Adams GE
    Radiat Res; 1992 Nov; 132(2):129-39. PubMed ID: 1438693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiosensitizers: rationale and potential.
    Brown JM
    Cancer Treat Rep; 1981; 65 Suppl 2():95-102. PubMed ID: 7346152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo.
    Denekamp J; Michael BD; Harris SR
    Radiat Res; 1974 Oct; 60(1):119-32. PubMed ID: 10881705
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of thiols in cellular response to radiation and drugs.
    Biaglow JE; Varnes ME; Clark EP; Epp ER
    Radiat Res; 1983 Sep; 95(3):437-55. PubMed ID: 6684310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay.
    Shibata T; Shibamoto Y; Sasai K; Oya N; Murata R; Takagi T; Hiraoka M; Takahashi M; Abe M
    Br J Cancer Suppl; 1996 Jul; 27():S61-4. PubMed ID: 8763848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.